These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 34960173)
1. COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health Decision. San Segundo D; Comins-Boo A; Lamadrid-Perojo P; Irure-Ventura J; Castillo-Otí JM; Wallman R; Calvo-Montes J; Méndez-Legaza JM; Baamonde-Calzada C; Sánchez-Molina I; Lecue-Martínez M; Ventisca-Pérez S; Batlle-López A; Hoyos ML Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960173 [TBL] [Abstract][Full Text] [Related]
2. Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination. Meyers E; De Rop L; Engels F; Gioveni C; Coen A; De Burghgraeve T; Digregorio M; Van Ngoc P; De Clercq N; Buret L; Coenen S; Deschepper E; Padalko E; Callens S; Duysburgh E; De Sutter A; Scholtes B; Verbakel JY; Heytens S; Cools P Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204074 [TBL] [Abstract][Full Text] [Related]
4. Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population. Witkowski W; Gerlo S; De Smet E; Wejda M; Acar D; Callens S; Heytens S; Padalko E; Vercruysse H; Cools P; Vandekerckhove L Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214717 [TBL] [Abstract][Full Text] [Related]
5. No Significant Association between 25-OH Vitamin D Status and SARS-CoV-2 Antibody Response after COVID-19 Vaccination in Nursing Home Residents and Staff. Meyers E; De Smet E; Vercruysse H; Callens S; Padalko E; Heytens S; Vandekerckhove L; Cools P; Witkowski W Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631911 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series. Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087 [TBL] [Abstract][Full Text] [Related]
8. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days. Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R Front Immunol; 2021; 12():726960. PubMed ID: 34671348 [TBL] [Abstract][Full Text] [Related]
9. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417 [TBL] [Abstract][Full Text] [Related]
10. Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response. Ontañón J; Blas J; de Cabo C; Santos C; Ruiz-Escribano E; García A; Marín L; Sáez L; Beato JL; Rada R; Navarro L; Sainz de Baranda C; Solera J EBioMedicine; 2021 Nov; 73():103656. PubMed ID: 34740112 [TBL] [Abstract][Full Text] [Related]
11. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection. Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492 [TBL] [Abstract][Full Text] [Related]
12. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study. Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952 [TBL] [Abstract][Full Text] [Related]
13. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521 [TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients. Melin J; Svensson MK; Albinsson B; Winqvist O; Pauksens K BMC Immunol; 2021 Oct; 22(1):70. PubMed ID: 34666683 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668 [TBL] [Abstract][Full Text] [Related]
16. Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Ferrari D; Clementi N; Criscuolo E; Ambrosi A; Corea F; Di Resta C; Tomaiuolo R; Mancini N; Locatelli M; Plebani M; Banfi G Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835288 [TBL] [Abstract][Full Text] [Related]
17. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
18. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis. Espi M; Charmetant X; Barba T; Koppe L; Pelletier C; Kalbacher E; Chalencon E; Mathias V; Ovize A; Cart-Tanneur E; Bouz C; Pellegrina L; Morelon E; Fouque D; Juillard L; Thaunat O Kidney Int; 2021 Oct; 100(4):928-936. PubMed ID: 34284044 [TBL] [Abstract][Full Text] [Related]
19. Antibody titres decline 3-month post-vaccination with BNT162b2. Favresse J; Bayart JL; Mullier F; Elsen M; Eucher C; Van Eeckhoudt S; Roy T; Wieers G; Laurent C; Dogné JM; Closset M; Douxfils J Emerg Microbes Infect; 2021 Dec; 10(1):1495-1498. PubMed ID: 34232116 [TBL] [Abstract][Full Text] [Related]
20. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign. Ferrari D; Mangia A; Spanò MS; Zaffarano L; Viganò M; Di Resta C; Locatelli M; Ciceri F; De Vecchi E Clin Chem Lab Med; 2021 Nov; 59(12):2019-2026. PubMed ID: 34614550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]